Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Peschanski

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
The British Journal of Dermatology|December 20, 2016
Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort studyP Senet, C Blas-Chatelain, P Levy, et al.
Human Gene Therapy|December 9, 2004
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I studyJ Bloch, A C Bachoud-Lévi, N Déglon, et al.
Experimental Neurology|February 23, 2000
Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's diseaseA Bachoud-Lévi, C Bourdet, P Brugières, et al.
Cell Death & Disease|February 19, 2016
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylationS Blondel, A-L Egesipe, P Picardi, et al.
Gene Therapy|November 7, 2007
Progress and prospects: gene therapy clinical trials (part 2)Eric Alton, Stefano Ferrari, Uta Griesenbach, et al.
Lancet (London, England)|December 29, 2000
Motor and cognitive improvements in patients with Huntington's disease after neural transplantationA C Bachoud-Lévi, P Rémy, J P Nguyen, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
The British Journal of Dermatology|December 20, 2016
Factors predictive of leg-ulcer healing in sickle cell disease: a multicentre, prospective cohort studyP Senet, C Blas-Chatelain, P Levy, et al.
Human Gene Therapy|December 9, 2004
Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I studyJ Bloch, A C Bachoud-Lévi, N Déglon, et al.
Experimental Neurology|February 23, 2000
Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's diseaseA Bachoud-Lévi, C Bourdet, P Brugières, et al.
Cell Death & Disease|February 19, 2016
Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new modulators of farnesylationS Blondel, A-L Egesipe, P Picardi, et al.
Gene Therapy|November 7, 2007
Progress and prospects: gene therapy clinical trials (part 2)Eric Alton, Stefano Ferrari, Uta Griesenbach, et al.
Lancet (London, England)|December 29, 2000
Motor and cognitive improvements in patients with Huntington's disease after neural transplantationA C Bachoud-Lévi, P Rémy, J P Nguyen, et al.
Pageof 12